238 results
8-K
EX-99.1
TEVA
Teva- Pharmaceutical Industries Ltd.
8 May 24
Teva Reports First Quarter 2024 Financial Results and Reaffirms 2024 Financial Outlook
7:01am
in the marketplace, including: that we are substantially dependent on our generic products; concentration of our customer base and commercial alliances
8-K
EX-99.1
ejsm8h0049r ksyw
31 Jan 24
Results of Operations and Financial Condition
7:00am
8-K
EX-99.1
7ak0 66kc7o08
8 Nov 23
2023 revenues outlook revised to $15.1 - $15.5 billion from $15.0 - $15.4 billion
7:01am
8-K
EX-99.1
mhve3g96nre4
24 Aug 23
Entry into a Material Definitive Agreement
7:30am
8-K
sc2r1h
24 Aug 23
Entry into a Material Definitive Agreement
7:30am
8-K
EX-99.1
lqhjl8stcdbs p4kh
2 Aug 23
Results of Operations and Financial Condition
7:00am
8-K
EX-99.1
d2op6cu61 t9xu39s
10 May 23
Results of Operations and Financial Condition
7:01am
8-K
EX-99.1
7awh 1w5fxdudvzjocu
3 Nov 22
Key financial highlights and outlook
7:00am
8-K
EX-99.1
683w8mo94zeh2s
26 Jul 22
Key financial highlights and outlook
4:56pm